Introduction 36
Patient acceptability is likely to have a significant effect on medicines adherence and 37 consequently on the safety and efficacy of the medicinal product. Recent EMA guidelines 38 have highlighted that the palatability of a medicine is one of the main elements of patient 39 acceptability of an oral paediatric medicinal product (EMA, 2013) . Palatability is defined as 40 the overall appreciation of a medicinal product in relation to its smell, taste, aftertaste and 41 texture (i.e. feeling in the mouth). It is determined by the characteristics of the active 42 substance, the way the active substance is formulated into a finished medicinal product and 43 by the characteristics of the excipients. 44
Much work has been done on the assessment of taste of medicines (e.g. ( properties of oral rehydration solutions in children, including the influence of texture by 48 comparing a "gelatine" and "gel" texture; their results showed that the "gel" texture was 49 preferred however, no further details on this finding were provided (Polanco Allué et al., 50 2012). The need to improve the texture of medicines was also highlighted for antiretroviral 51 therapies (2004; Gibb et al., 2003) , although details on textural issues were not explicitly 52 reported. The texture of nelfinavir powder has been reported to be an issue in terms of 53 palatability of medicines (Reddington et al., 2000; Van Dyke et al., 2002) . Nelfinavir is 54 administered in large volumes, for instance, at the dose of 55 mg/kg BID, an average 6-year-55 old is required to take 25 scoops (6.25 teaspoons) of nelfinavir powder, with food, twice a 56
day. 57
A recent study investigated barriers to medicines administration in children and although 58 taste was the most reported issue in medicines refusal texture was the next most frequent 59 reason for refusal . Specific medicines identified with textural issues 60 included: lactulose which was described as "oily" and co-trimoxazole liquid described as 61 "thick and gelatinous" (Venables, 2014) . 62
There are no reports on the ideal mouthfeel of a liquid medicine; however it is intuitive to 63 suggest that this needs to be smooth and in the case of a bad tasting medicine a product 64 that is swallowed rapidly and leaves minimal residue on the oral cavity surfaces. Positive 65 attributes of oral formulations reported in a recent study described good textures as being 66 "sherbet" and "fizzy" (Venables, 2014) . 67
The mouthfeel of a medicine can be defined as the sensation from the ingestion, mastication 68 and swallowing of the medicine, all of which are influenced by the physical and chemical 69
properties of the medicine being administered. The majority of mouthfeel research has been 70 conducted on foods where there is a tendency to want to maximise sensory pleasure in food 71 consumption to drive preferences in food choices, however, there are key differences 72 required in assessing the mouthfeel of medicines. Medicines are designed to be acceptable 73 rather than preferred choices and there is no requirement to maximise sensory pleasure. 74
Nevertheless, it is critical that the mouthfeel of a medicine is not a barrier to administration. 75
Orally administered medicines are manipulated by the tongue, teeth, inside of the cheeks 76 and lips whilst in the oral cavity; this subjects the medicine to forces at a range of speeds 77 and pressures (Prinz et al., 2007) . There are various sensory textural attributes that patients 78 perceive whilst taking oral medicines (as with foods) including hardness, softness, grittiness, 79 creaminess, adhesiveness, slipperiness and many others (De Wijk and Prinz, 2006) . . In general, it is accepted 91 that while tribology does not provide a one-to-one relation to processing in the mouth, when 92 combined with a number of other characterisation techniques such as rheology, it can offer 93 valuable information on material behaviour. This knowledge can then be used to help guide 94 the design of new products. This paper describes the first use of tribology to assess the 95 lubricating properties of oral liquids. 96
In brief, tribology measures the friction between two interacting surfaces, in this case a steel 97 ball on a silicone elastomer disk. Lubrication is often categorised by measuring the friction 98 coefficient across a range of speeds as the extent of lubrication will vary. Often this data is 99 presented as a Stribeck curve, which shows the traction coefficient as a function of speed of 100 motion between surfaces. The Stribeck curve usually has three phases: In terms of application of tribology to liquid medicines in the mouth we are mostly interested 114 in low to intermediate speed movement (boundary/mixed regime as described above) to 115 assess the ability of a medicine to coat the oral cavity as we hypothesise that a low-residue 116 (non-coating) product is likely to be preferred and it is these regions that have previously 117 been identified to be most relevant when considering oral processing (Malone et al., 2003) . 118
Many oral liquid medicines are formulated as suspensions where drug particles are 119 undissolved within the bulk liquid. The size of the drug particles will influence their mouthfeel 120 as they may result in a gritty texture. Previous work conducted reported that particles as 121 small as 2 µm could be detected in food by trained adult panels (Engelen et al., 2005a) . 122
However, the perception of size of particles was influenced by their characteristics where 123 hard and irregular particles are perceived as larger than soft and round particles of similar 124 size (Engelen et al., 2005b) . 125
The objective of the present study is to evaluate the effectiveness of tribology as a tool to 126 differentiate between oral liquid medicines based on qualitative feedback regarding their 127 texture. The frictional response of each liquid is measured over a range of speeds to map 128 the Stribeck response for each product and compared with viscosity to emphasise the 129 different information that can be gained from this method. We highlight the potential of 130 tribological measurement to provide insights into texture and mouthfeel perception of 131 medicines. 132 2 Materials and methods 133
Medicinal products 134
Oral liquid medicines were selected based on qualitative data from previous work where co-135 trimoxazole (Septrin®) and Lactulose were reported as having thick and oily textures 136 respectively (Venables, 2014) . Calpol® infant sugar free 120mg/5mL suspension is typically 137 reported to be an ideal medicine in terms of palatability and therefore this was used as a 138 control. Other generic paracetamol suspensions were investigated to observe whether 139 tribology could differentiate between brands. Gritty or "dry" products are anticipated to show high traction coefficients at low speeds due to 194 their lack of lubrication and surface coating. Many liquid medicines are suspensions with 195 particle sizes ranging from 1 to 50 µm (Allen et al., 2005) . However, there is currently no 196 data that correlates grittiness perception in medicines to particle size. This study used 197 products with particle sizes that are known to be detectable in human panel studies which 198 also represent typical liquid medicines. The fact that Calpol® does not result in higher friction 199 values or a gritty mouthfeel despite having particles large enough to be perceived could 200 suggest that, as suggested by Engelen et al., the particles are not hard enough to affect 201 perception or that their shape is affecting their perception (Engelen et al., 2005a) . For the 202 generic paracetamol samples a large difference is identified between the different brands 203 with the 250 mg/5mL product being more lubricating overall and very similar to the Calpol® 204 formulation. When compared to viscosity (see Figure 2 ) at lower shear rates both generic 205 products behave similarly to each other, with the Calpol® at a reduced viscosity at lower 206 shear rates, however the 120 mg/5mL product is more shear thinning (i.e. viscosity reduces 207 with increasing shear rate) which would suggest a reduced ability to support the contacting 208 surfaces and reduce lubrication for the tribology measurement. These differences are 209 expected since the different brands would use different formulations but these changes in 210 behaviour highlight why two products may have very different feedback on their palatability 211 despite containing the same quantity of active ingredient. 212 Both Septrin® formulations show very similar lubrication behaviour and viscosity over the 213 studied range, which could be expected since they are both from the same manufacturer. 214
Despite having different concentrations of active ingredient these results suggest that the 215 excipients likely dominate the material behaviour, so any differences experienced in liking 216 are expected to be from flavour cues. The approach to maintain this behaviour for both adult 217 and paediatric formulations may not be the best design approach since differences in 218 preferences would likely exist at different ages. 219
These results have demonstrated that tribology can detect differences in oral liquid 220 medicines which may relate to mouthfeel. There are also further opportunities to use 221 tribology in a wider range of oral medicines including orally disintegrating tablets, chewable 222 tablets, oral films and gels. 223 224 Stribeck curves (coefficient of friction versus speed) of measured samples. The mean particle size of the 4 largest particles present in each product was measured 234 manually via the scale bar from at least 3 representative images. This technique provides a 235 simple means of measuring the particle size of the largest particles present in each product, 236 as the larger particles are likely to dominate mouthfeel. 237
The results in Table 1 The particle size varied between products, as did the number of particles present. However, 242
Calpol® contained particles of the largest dimensions (although not statistically significantly 243 larger (p>0.05) in this estimated methodology) yet there are no mouthfeel issues associated 244 with this product. This may also be due to the taste being the most important factor, which 245 masks potentially problematic mouthfeel. All products had particles greater than 2 µm which 246 was previously reported as detectable in food by trained adult panels (Engelen et al., 247 2005a ). However, it may be expected that medicines contain particles and grittiness may not 248 be reported as an issue in such products. 
Conclusions 263
These results highlight the use of tribology as a tool to understand lubrication processes 264 involving oral liquid medicines and the unique information it can provide. However, like any 265 physical in vitro technique, it is still difficult to directly relate tribological measurement to 266 sensory perception and developments therefore additional work is required to better utilise 267 sensory panel and in vitro data from a range of measurements for future products. The 268 application of tribology in this context has the potential to add value to the design process by 269 allowing measurements at a different scale to rheology and more traditional methods. This 270 could play a crucial role in the rational design of oral liquid medicines with high consumer 271 acceptability. 272
